Catramol Mechanism of Action

tramadol + paracetamol




Full Prescribing Info
Pharmacology: Tramadol is a centrally acting synthetic opioid analgesic. Although its mode of action is not completely understood, from animal test, at least two complementary mechanism appear applicable: binding of parent and M1 metabolite to μ-opioid receptors and weak inhibition of reuptake of norepinephrine and serotonin.
Opioid activity is due to both low affinity binding of the parent compound and higher affinity binding of the O-demethylated metabolite M1 to μ-opioid receptors. In animal models, M1 up is to 6 times more potent than Tramadol in producing analgesia and 200 times more potent in μ-opioid binding. Tramadol-induced analgesia is only partially antagonized by the opiate antagonist naloxone in several animal tests. The relative contribution of both Tramadol and M1 to human analgesia is dependent upon the plasma concentrations of each compound.
Tramadol has been shown to inhibit reuptake of norepinephrine and serotonin in-vitro, as have some other opioid analgesics. These mechanism may contribute independently to the overall analgesic profile of Tramadol.
Apart from analgesia, Tramadol administration may produce a constellation of symptoms (including dizziness, somnolence, nausea, constipation, sweating, and pruritus) similar to that of other opioids.
Paracetamol is a non-opiate, non-salicylate analgesic.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in